Table 4.
Screening Type | Sub-Group | Studies Included (References) |
Pooled Estimate (95% CI) |
Heterogeneity (I2) |
---|---|---|---|---|
Breast cancer | Visual impairment | N = 3 studies [5,20,33] | 0.63 (0.51–0.77) | 95% |
Breast cancer | Psychosocial | N = 7 studies [22,23,24,25,26,31,32] | 0.69 (0.60–0.80) | 100% |
Cervical cancer | Psychosocial | N = 6 studies [22,24,27,28,29,32] | 0.64 (0.34–1.18) | 100% |